Relationship between the presence of comorbidities and risk of death in obese patients diagnosed with COVID-19 (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorARAÚJO, GABRIEL QUIXABEIRA BEZERRA DE-
Autor(es): dc.contributor.authorSILVA, AGEO MARIO CANDIDO DA-
Autor(es): dc.contributor.authorWEIS, WESLEY ARAUJO-
Autor(es): dc.contributor.authorMORENO, GABRIELA VASCONCELOS-
Autor(es): dc.contributor.authorRODRIGUES, KEREN LOUANA GONÇALES-
Autor(es): dc.contributor.authorCIGERZA, PABLO MARINHO-
Autor(es): dc.contributor.authorDAMBROS, PEDRO VITOR KRUGER-
Autor(es): dc.contributor.authorSILVA, JARBAS FERREIRA SEGUNDO-
Autor(es): dc.contributor.authorSILVA, MARIA ISABELLA DA CRUZ-
Autor(es): dc.contributor.authorGUILHERME, PEDRO CASTIGLIONI-
Autor(es): dc.contributor.authorMELLO, VANESSA MACHADO DE-
Autor(es): dc.contributor.authorSALDANHA, EDUARDO QUEIROZ-
Autor(es): dc.contributor.authorSALOMÃO, ALBERTO BICUDO-
Data de aceite: dc.date.accessioned2023-09-06T20:19:02Z-
Data de disponibilização: dc.date.available2023-09-06T20:19:02Z-
Data de envio: dc.date.issued2023-09-01-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/737756-
Resumo: dc.description.abstractIntroduction: Obesity is a risk factor for mortality in COVID-19. Comorbidities present in these patients may be related to a worse outcome of COVID-19. Objective: to investigate in obese patients with COVID-19 the association between cardiovascular, hematological, neurological, hepatic, pulmonary, renal, diabetes, bronchial asthma and immunosuppression with death. Method: A total of 4,243 cases were evaluated through a retrospective cohort study, with obese patients diagnosed with COVID-19. Data were obtained from the “COVID-19 Surveillance Database for Severe Acute Respiratory Syndrome Surveillance”, available at Open DATASUS, 2020. Overall mortality was evaluated and stratified according to comorbidities, focusing on the risk association with death. Results: Overall mortality was 33.8%, increased among patients aged ≥60 years, non-white, with a lower level of education and from rural areas. Comorbidities related to the risk of death were cardiovascular disease (41.39%; RR 1.53; CI95 1.40-1.67), diabetes mellitus (42.83%; RR 1.48; CI95 1.36-1.61), chronic lung diseases (56.07%; RR 1.71; CI95 1.51-1.95), immunosuppression (53.7%; RR 1.61; CI95 1.34-1.93), disease renal (58.67%; RR 1.79; CI95 1.58-2.03) and neurological (mortality 47.01%; RR 1.40; CI95 1.17-1.69).Conclusion: The presence of chronic kidney disease, chronic lung disease, immunosuppression, cardiovascular disease and diabetes mellitus were associated with a higher risk of death in obese patients with COVID-19.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectcoronaviruspt_BR
Título: dc.titleRelationship between the presence of comorbidities and risk of death in obese patients diagnosed with COVID-19 (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais